- Company Directors - P
- Phillips Barclay A
Insider Trading History of Phillips Barclay A
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Phillips Barclay A since 2008.
The trader's CIK number is 1265801.
At the time of the last reporting, Phillips Barclay A was the Officer of G1 Therapeutics, Inc.. (stock ticker symbol GTHX).
Also see all insider trading activities at G1 Therapeutics, Inc..
Note that in the past
PHILLIPS BARCLAY A also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Cancervax Corp (MITI) by Phillips Barclay A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | MITI | 0 | $0 | 35,000 | $213,605 | 35,000 | $88,900 |
Yearly summary of insider trading at Novavax Inc (NVAX) by Phillips Barclay A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2017 | NVAX | 28,690 | $24,608 | 0 | $0 | 0 | $0 |
| 2016 | NVAX | 827 | $3,583 | 0 | $0 | 0 | $0 |
| 2015 | NVAX | 9,152 | $20,865 | 28,656 | $374,323 | 0 | $0 |
| 2014 | NVAX | 28,656 | $84,408 | 0 | $0 | 0 | $0 |
| 2013 | NVAX | 50,000 | $95,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at G1 Therapeutics, Inc. (GTHX) by Phillips Barclay A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | GTHX | 0 | $0 | 5,000 | $199,590 | 5,000 | $97,300 |
Yearly summary of insider trading at Acorda Therapeutics Inc (ACOR) by Phillips Barclay A
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2008 | ACOR | 0 | $0 | 235,000 | $7,176,900 | 0 | $0 |
Insider trading activities at 4 companies by Phillips Barclay A:
1. Cancervax Corp (MITI)
2. Novavax Inc (NVAX)
3. G1 Therapeutics, Inc. (GTHX)
4. Acorda Therapeutics Inc (ACOR)
Table 1. Insider trading of Cancervax Corp (MITI) by Phillips Barclay A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-11-09 | MITI | Option Ex | 35,000 | 2.54 | 88,900 |
| 2009-11-09 | MITI | Sale | 35,000 | 6.10 | 213,605 |
Table 2. Insider trading of Novavax Inc (NVAX) by Phillips Barclay A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2017-07-31 | NVAX | Buy | 2,057 | .89 | 1,830 |
| 2017-05-11 | NVAX | Buy | 25,000 | .84 | 20,950 |
| 2017-01-31 | NVAX | Buy | 1,633 | 1.12 | 1,828 |
| 2016-07-31 | NVAX | Buy | 422 | 4.29 | 1,810 |
| 2016-01-31 | NVAX | Buy | 405 | 4.38 | 1,773 |
| 2015-08-19 | NVAX | Sale | 18,656 | 13.20 | 246,203 |
| 2015-08-20 | NVAX | Sale | 10,000 | 12.81 | 128,120 |
| 2015-07-31 | NVAX | Buy | 764 | 2.28 | 1,741 |
| 2015-01-31 | NVAX | Buy | 8,388 | 2.28 | 19,124 |
| 2014-10-03 | NVAX | Buy | 5,000 | 4.11 | 20,550 |
| 2014-07-31 | NVAX | Buy | 8,788 | 2.28 | 20,036 |
| 2014-03-25 | NVAX | Buy | 5,000 | 4.25 | 21,225 |
| 2014-01-31 | NVAX | Buy | 9,868 | 2.29 | 22,597 |
| 2013-06-12 | NVAX | Buy | 50,000 | 1.90 | 95,000 |
Table 3. Insider trading of G1 Therapeutics, Inc. (GTHX) by Phillips Barclay A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-11-15 | GTHX | Option Ex | 5,000 | 19.46 | 97,300 |
| 2018-11-15 | GTHX | Sale | 5,000 | 39.92 | 199,590 |
Table 4. Insider trading of Acorda Therapeutics Inc (ACOR) by Phillips Barclay A
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2008-06-13 | ACOR | Sale | 235,000 | 30.54 | 7,176,900 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Phillips Barclay A
(Officer of G1 Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.